Enhancement of Enzymatic EnantioselectiVity
J. Am. Chem. Soc., Vol. 121, No. 14, 1999 3339
Table 6. Comparison of the Experimentally Determined
Enantioselectivities of Cross-linked Crystalline Subtilisin Carlsberg
toward 5 and Its Salts with Molecular Modeling Dataa
enantiomers in chiral HPLC). Using a mobile phase of 99% hexane/
1% 2-propanol/0.1% diethylamine (henceforth, all such percentages are
v/v/v) with a flow rate of 0.80 mL/min and a Chiralcel OD-H column,
R- and S-1 were separated with retention times of 34.4 and 38.6 min,
respectively.
area of surface overlap (ASO), Å2
substrate
E (S/R)
S
R
R-S
Racemic 2 was synthesized21 by dissolving 200 mg of (()-
phenylalanine in 20 mL of anhydrous propanol, followed by refluxing
with simultaneous purging with dry HCl gas. The resulting reaction
mixture was concentrated in a vacuum and cooled, and the crystals
were filtered off and recrystallized from propanol (yield of 130 mg,
5
1.5 ( 0.1
2.8 ( 0.2
3.1 ( 0.3
3.6 ( 0.3
4.3 ( 0.4
6.9 ( 0.5
27.0
34.3
40.1
36.3
39.8
42.5
45.3
27.9
36.8
43.1
40.6
44.2
47.4
50.7
0.9
2.5
3.0
4.3
4.4
4.9
5.4
5‚3,5-lutidine
5‚isoquinoline
5‚quinuclidine
5‚1-adamantanamine
5‚4-phenylpyridine
1
60% of theoretical). H NMR (CDCl3) δ 7.37 (5H, m), δ 4.20 (1H,
m), 3.84 (2H, t, J ) 7.2 Hz), 3.30 (1H, dd, J ) 6.2, 11.5 Hz), 3.19
(1H, dd, J ) 4.6, 11.4 Hz), 1.64 (2H, m), 7.3 (3H, t, J ) 7.7 Hz). To
determine the elution sequence of the enantiomers, R-2 was synthesized
the same way except for using R-Phe as a starting material. Using the
same chiral HPLC conditions as for 1, R- and S-2 had retention times
of 23.2 and 25.6 min, respectively.
Using the procedure of McKenzie and Wood,22 (()-3 was recrystal-
lized three times with equimolar quinine in ethanol to give R-3 with
an e.e. of 96%, as determined by chiral HPLC. Using a mobile phase
of 96% hexane/4% 2-propanol/0.1% trifluroacetic acid with a flow rate
of 0.50 mL/min and a Chiralcel OD-H column, R- and S-3 had retention
times of 40.7 and 46.0 min, respectively.
Racemic 4 was synthesized23 by dissolving 250 mg of (()-3 in 20
mL of dry tetrahydrofuran, and 200 mg of acetyl chloride was added
dropwise at 4 °C. The resulting reaction mixture was stirred at room
temperature overnight and then quenched by addition of 20 mL of water.
After extraction with ethyl acetate three times, the product was dried
over MgSO4, concentrated by rotary evaporation, and purified by flash
silica gel column chromatography (yield of 213 mg, 68% of theoretical).
1H NMR (CDCl3) δ 7.32 (5H, s), 4.57 (dd, 1H, J ) 9.5, 10.9 Hz),
4.34 (dd, 1H, J ) 9.5, 10.9 Hz), 3.95 (dd, 1H, J ) 5.5, 9.5 Hz), 2.03
(s, 3H). R-4 was prepared the same way from R-3 in order to determine
the HPLC elution sequence of 4. Using the same chiral HPLC
conditions as for 3, R- and S-4 had retention times of 22.6 and 20.5
min, respectively.
5‚4-(4-chlorobenzoyl)- 8.1 ( 0.6
pyridine
a The E values are for the hydrolysis depicted in Scheme 3 in tert-
amyl alcohol containing 1% water. The molecular modeling (Figure
3) data include the areas of the van der Waals surfaces of the substrate
transition states that overlap with those of the enzyme, as well as the
difference in that parameter between the R and S enantiomers. The E
values were taken from the first column of Table 5. For more details,
see footnotes to Table 2 and Methods.
solvents, as well as different enzymes and reactions catalyzed
by them. The results suggest that, at least for the instances
examined, the steric hindrances suffered by the less reactive
substrate enantiomer in the enzyme-bound transition state are
the predominant reason for enzymatic enantiodiscrimination;
when these hindrances are exacerbated further by enlarging the
substrate due to salt formation, the enantioselectivity rises. It is
also clear that the substrate salts remain intact even in the
enzyme-active sites. Molecular modeling of R and S enzyme-
bound transition states, for both the free substrates and their
various salts, reveals a surprisingly good correlation in each
substrate series between experimentally determined E values
and the calculated differential areas of surface overlap (ASO
for the less reactive enantiomer minus that for the more reactive
one). The proposed enantioselectivity enhancement strategy is
effective in organic solvents but not in water (where the salts
evidently dissociate thus reverting to the free substrates). Thus
the present work points to novel synthetic opportunities afforded
by nonaqueous enzymatic catalysis. In addition to the salt
formation explored herein, these presumably may also include
other reversible complexes stable in organic solvents but not in
water.
R-4 was also prepared enzymatically from (()-3‚quinuclidine salt
(formed by refluxing, as described below). The salt (3 mg, 1.20 mmol)
and 520 mg of vinyl acetate (6 mmol) were dissolved in 30 mL of
acetonitrile, followed by addition of 60 mg of CLC P. cepacia lipase.
The reaction mixture was shaken at 30 °C and 300 rpm. Once the overall
conversion reached 35% (12.1 h), as judged by chiral HPLC, the
reaction was stopped by filtering off the enzyme, and the filtrate was
concentrated by rotary evaporation. The residue was redissolved in a
small amount of the mobile phase (60% ethyl acetate/40% hexane/
0.1% trifluroacetic acid) to decompose the salt, purified with flash silica
gel column chromatography, and yielded 75 mg of R-4 (30% of
Materials and Methods
1
theoretical yield, 65% e.e. as determined by chiral HPLC). H NMR
(CDCl3) δ 7.34 (5H, s), 4.60 (dd, 1H, J ) 9.5, 11.1 Hz), 4.37 (dd, 1H,
J ) 9.4, 11.0 Hz), 3.95 (dd, 1H, J ) 5.5, 9.5 Hz), 2.06 (s, 3H). Using
the same procedure, the acetylation of 3 was carried out for 8.4 h, which
yielded 78 mg of R-4 (32% of theoretical yield, 6% e.e. as determined
by chiral HPLC). 1H NMR (CDCl3) δ 7.21 (5H, s), 4.61 (dd, 1H, J )
9.9, 11.4 Hz), 4.31 (dd, 1H, J ) 9.3, 11.8 Hz), 3.90 (dd, 1H, J ) 5.7,
9.2 Hz), 2.01 (s, 3H).
Using a mobile phase of 97.5% hexane/2.5% 2-propanol/0.1%
trifluroacetic acid with a flow rate of 0.80 mL/min and a Chiralcel
OD-H column, R-5, S-5, R-6, and S-6 had retention times of 27.4, 32.3,
40.7, and 54.5 min, respectively.
Enzymes. Cross-linked crystals of P. cepacia lipase, C. rugosa
lipase, and subtilisin Carlsberg were gifts from Altus Biologics, Inc.
γ-Chymotrypsin was crystallized and cross-linked with glutaraldehyde
using the previously described procedure.15 Prior to use, enzyme crystals
were filtered, washed twice with dry acetonitrile and then twice with
the corresponding solvent.
Lyophilized enzyme powders were prepared as follows: the enzyme
was dissolved (5 mg/mL) in 20 mM aqueous phosphate buffer of pH
7.0 or 7.8 (for P. cepacia lipase and subtilisin Carlsberg, respectively)
at 4 °C, then the solution was frozen using liquid N2, and lyophilized
for 48 h.
Kinetic Measurements. In the propanolysis of 1 in anhydrous
solvents (Scheme 1), 10 mg/mL of lipase, 40 mM racemic 1, and 200
mM propanol were used, while for the hydrolysis of 1 in 10 mM
aqueous phosphate buffer (pH 7.0), 10 mM racemic 1 and 0.2 mg/mL
of enzyme were used. For the acetylation of 3 (Scheme 2), 2 mg/mL
of lipase, 40 mM racemic 3, and 200 mM vinyl acetate were used. In
the hydrolysis of 5 in organic solvents (Scheme 3), 10 mg/mL of
subtilisin, 40 mM racemic 5, and 1% (v/v) of deionized water were
Chemicals and Solvents. Most of the chemicals and solvents used
in this work were purchased from Aldrich Chemical Co. and Sigma
Chemical Co. R- and S-5 were from Chirotech Technology Ltd., and
(()-6 was from Narchem Corp. Organic solvents were of the highest
purity available from Aldrich (analytical grade or better) and were dried
prior to use by shaking with Linde’s 3-Å molecular sieves.
(()-1 was prepared by dissolving 1.0 g of its hydrochloride in 40
mL of deionized water and adjusting the pH to 10. This solution was
extracted with 50 mL of ethyl acetate thrice, followed by combining
the organic layers and drying over anhydrous MgSO4. Subsequent rotary
evaporation resulted in 0.74 g of (()-1 (90% of theoretical yield). R-1
was prepared the same way (to determine the elution sequence of the
(21) Vanderhaeghe, H. J. Pharm. Pharmacol. 1954, 6, 57-59.
(22) McKenzie, A.; Wood, J. K. J. Chem. Soc. 1919, 828-834.
(23) Wolffenstein, M. Chem. Ber. 1908, 41, 730-736. Schmidt, R. J.
Pharm. Sci. 1968, 57, 443-452.